Fidelity International’s BioNTech BNTX Stock Holding History

Fidelity International’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.28K	Hold	46	–	–	﹤0.01%	1139
2026 Q1	$4.09K	Buy	+46	New	+$4.73K	﹤0.01%	1099

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Fidelity International's BNTX Position: Q2 2026 in Review

Fidelity International held its BioNTech (BNTX) position steady in Q2 2026 at 46 shares worth $4.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Fidelity International first reported a position in BNTX in Q1 2026 and has held it in 2 quarters since. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Fidelity International held 46 shares of BioNTech worth $4.28K as of Q2 2026.
Fidelity International left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #1139 holding.
Fidelity International first reported a position in BioNTech in Q1 2026 and has held it in 2 quarters since.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.